Merck KGaA (MRK.DE) Financial Analysis & Valuation | Quarter Chart
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industri... more
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science... more
Company facts
Reported company information and share structure.
Company
Share structure
| Market Cap | $72.58B | Exchange | XETRA |
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Country | DE | CEO | Kai Beckmann |
| IPO Date | 1998-06-26 | CAGR | 4.66% |
| Employees | 62,136 | Website | www.merckgroup.com |
| Div. Yield | 4.42% | Payout Ratio | 44% |
| Buy Back Yield | — | Total Yield | 4.42% |
MRK.DE chart loading...
Key metrics
Reported fundamentals and market-derived technical indicators.
Fundamentals
Technicals
| EV | $87.99B | P/E | 17.71 | Forward P/E | 16.56 | PEG | -1.12 |
| P/S | 1.02 | P/B | 0.71 | P/CF | 5.14 | P/FCF | 8.27 |
| Sales | $24.36B | Sales 1Y | -0.4% | Sales 3Y | -4.2% | Sales 5Y | 13.96% |
| EPS | $9.43 | EPS 1Y | -17.17% | EPS 3Y | -23.02% | EPS 5Y | -13.22% |
| Sales QoQ | 5.84% | EPS QoQ | -25.66% | Sales QoQ Avg | 0.89% | EPS QoQ Avg | 13.96% |
| Gross Margin | 58.69% | Operating Margin | 19.68% | Profit Margin | 11.22% | ROCE | 9.34% |
| ROA | 5% | ROE | 8% | Altman Z Score | 3.13 | Piotroski Score | 6 |
| Current Ratio | 1.69 | Quick Ratio | 1.09 | Cash Ratio | 0.24 | Op. CF Ratio | 0.07 |
| Debt/Equity | 0.41 | Debt/Assets | 0.23 | Lt Debt/Equity | 0.37 | Lt Debt/Cap. | 0.26 |
| Intrst Cov. | 8.52 | Inventory Turnover | 1.79 | Asset Turnover | 0.4 | Receivables Turnover | 4.31 |
| Enterprise Value | $87.99B | P/E Ratio | 17.71 |
| Forward P/E | 16.56 | PEG Ratio | -1.12 |
| P/S Ratio | 1.02 | P/B Ratio | 0.71 |
| P/CF Ratio | 5.14 | P/FCF Ratio | 8.27 |
| EPS | $9.43 | EPS Growth 1Y | -17.17% |
| EPS Growth 3Y | -23.02% | EPS Growth 5Y | -13.22% |
| Revenue Growth 1Y | -0.4% | Gross Margin | 58.69% |
| Operating Margin | 19.68% | Profit Margin | 11.22% |
| ROE | 8% | ROA | 5% |
| ROCE | 9.34% | Current Ratio | 1.69 |
| Quick Ratio | 1.09 | Cash Ratio | 0.24 |
| Debt/Equity | 0.41 | Interest Coverage | 8.52 |
| Altman Z Score | 3.13 | Piotroski Score | 6 |
Merck KGaA (MRK.DE) valuation & financials
Merck KGaA (MRK.DE) has a market capitalization of $72.58B and trades at a price-to-earnings ratio of 17.7. It operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Merck KGaA's revenue grew -0.4% over the last year.
Merck KGaA's next earnings report is scheduled for November 12, 2026 (provider scheduled date); analysts estimate EPS of $2.30. Check the earnings calendar to see all companies reporting this week.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)